← Back to headlines
Emergent BioSolutions Targets $720M–$760M Revenue by 2026 Amid Transformation Plan
Emergent BioSolutions has outlined a revenue target of $720 million to $760 million for 2026, as the company continues to advance its ongoing transformation plan.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Volkswagen Announces Major Restructuring Plan With Up to 100,000 Job Cuts
13m ago
US Investigates Deadly Strike on Iranian Wedding Linked to American Munitions
39m ago
US-Venezuela Oil Deal Sparks Criticism Over Viability and Colonialism Claims
54m ago
OpenAI Pledges One Billion Dollars to Fund Cybersecurity Initiatives
1h ago